Based in East and West Cheshire the AAT provides services for assessment and diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) and ADHD treatment and medication monitoring, if required, in East Cheshire, and assessment and diagnosis of Autism in East and West Cheshire. This does not include children and young people who access health services from Winsford, Northwich, Bunbury, Frodsham or Helsby practices (unless they live in Elton). The Team is not commissioned to offer post-diagnostic support for Autism , however will signpost to resources and services available in the local area.
Assessment and monitoring clinics are held at various locations in the local area, with main bases at Elm House and Space4Autism in East Cheshire and Marsden House in West Cheshire.
16-17 year old young people : ( Cheshire East & Cheshire West & Chester)
The Adult ADHD service is currently closed to referrals with the exception of the below:
- 16–17-year-old Cheshire GP patients
- Cheshire GP patients with an established ADHD diagnosis who are receiving ADHD medication without specialist support.
- Transitions from paediatric services
Enquiries to: cwp.
Referrals to : cwp.
If patient does not meet above criteria, you may wish to refer to interim ADHD service via Right to Choose: https://adhduk.co.uk/right-to-choose/ ) as an alternative to waiting until we reopen to new referrals.
ADHD diagnostic assessment
The ADHD Team provides assessment to children and young people aged 6-16 years who have a GP in Cheshire East. The team accepts referrals for children and young people who have not received a previous diagnosis of ADHD.
ADHD treatment and medication monitoring
This service is available to children and young people aged 6-16 years who have received a diagnosis of ADHD and have a GP in Cheshire East.
Autism diagnostic assessment
The Autism Team provides assessment to children and young people aged 4-16 years and who have a GP in Cheshire East, and to children and young people aged 11-16 years and who have a GP in Cheshire West. This does not include children and young people who access health services from Winsford, Northwich, Bunbury, Frodsham or Helsby practices (unless they live in Elton). The Team accepts referrals for children and young people who have not received a previous diagnosis of Autism.
16-17 year olds - cheshire:
The Adult ADHD service is currently closed to referrals with the exception of the below:
- 16–17-year-old Cheshire GP patients
- Cheshire GP patients with an established ADHD diagnosis who are receiving ADHD medication without specialist support.
- Transitions from paediatric services
Enquires to: cwp.
Referrals to : cwp.
If patient does not meet above criteria, you may wish to refer to interim ADHD service via Right to Choose: https://adhduk.co.uk/right-to-choose/ ) as an alternative to waiting until we reopen to new referrals.
ADHD and Autism Assessment Service Providers
For Cheshire West please refer via the Community Paediatric Service
For Cheshire East referrals are made online via the online referral form on this page.
ADHD areas covered
- East Cheshire – age 6-16 years
- Poynton
- Wilmslow
- Macclesfield
- Knutsford
- Congleton
- Holmes Chapel
Details of other providers for ADHD
- West Cheshire – age 6-16 years
- Community Paediatric team via Kingsway Children’s Centre Kingsway Chester CH2 2LB.
- 01244 366724
- https://
www. livewell.cheshirewestandchester.gov.uk/ Services/ 301/ Community-Paediatric
- East and West Cheshire – age 16+
- Adult ADHD team
- 0300 303 3157
- cwp.
adhdreferrals @nhs.net
ASC areas covered
- East Cheshire – age 4-18 years
- Poynton
- Wilmslow
- Macclesfield
- Knutsford
- Congleton
- Holmes Chapel
Details of other providers for ASC
- West Cheshire – age 0-16 years
-
- Community Paediatric team via Autism Coordinator, Kingsway Children’s Centre Kingsway Chester CH2 2LB.
- 01244 366724
- www.
livewell.cheshirewestandchester.gov.uk/ Services/ 301/ Community-Paediatric
- East Cheshire – age 18+
- West Cheshire – age 16+
- Adult ASD service
- 01244 397640
- cwp.
adultautismreferrals @nhs.net
Submit an online referral to our CYP ADHD and Autism Service
List of pages
SEND Partnership briefing on ADHD and ASC (North) East Cheshire
East Cheshire ADHD transition process to adult services
There are supply disruptions affecting various strengths of the following medications which are licensed for the treatment of attention deficit hyperactivity disorder (ADHD):
• Methylphenidate:*
Equasym XL® 10, 20 and 30 mg capsules
Xaggitin XL® 18 and 36 mg prolonged-release tablets
Concerta XL® 54 mg prolonged-release tablets
Xenidate XL® 27 mg prolonged-release tablets
• Lisdexamfetamine:
Elvanse® 20, 30, 40, 50, 60 and 70 mg capsules
Elvanse® Adult 30, 50, and 70 mg capsules
• Guanfacine:
Intuniv® 1, 2, 3 and 4 mg prolonged-release tablets
At present, the supply disruptions are expected to resolve at various dates between October and December 2023
• Atomoxetine:
The Department of Health and Social Care (DHSC) issued a Medicine Supply Notification in August 2023 for the shortage of atomoxetine capsules. The supply issue with atomoxetine is set to resolve in October 2023.
The supply disruption of these products is caused by a combination of manufacturing issues and an increased global demand.
The following medications, also commonly used to treat ADHD, continue to be in good supply.
Methylphenidate immediate release tablet:
- Tranquilyn
- Ritalin
- Medikinet
Methylphenidate (8-hour release):
- Medikinet XL prolonged release capsules
Methylphenidate prolonged release tablets (12-hour release):
- Matoride XL
- Delmosart XL
- Affenid XL (these can be used as a direct replacement for affected strengths of Concerta Xl, Xenidate XL, Xaggitin XL)
